FDA Approves Irritable Bowel Syndrome Drug Ibsrela for Adults
According to a press release from the California-based biotechnology company Ardelyx, the US Food and Drug Administration (FDA) recently approved the company's irritable bowel syndrome drug candidate Ibsrela (generic name…